BICO Group AB Stock

Equities

BICO

SE0013647385

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm 11:29:59 2024-05-31 am EDT 5-day change 1st Jan Change
44.82 SEK -2.01% Intraday chart for BICO Group AB +1.17% -21.31%
Sales 2024 * 2.49B 236M Sales 2025 * 2.89B 275M Capitalization 3.16B 301M
Net income 2024 * 14M 1.33M Net income 2025 * 131M 12.45M EV / Sales 2024 * 1.82 x
Net Debt 2024 * 1.36B 129M Net Debt 2025 * 1.67B 158M EV / Sales 2025 * 1.67 x
P/E ratio 2024 *
224 x
P/E ratio 2025 *
24.1 x
Employees 837
Yield 2024 *
-
Yield 2025 *
-
Free-Float 60.54%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.01%
1 week+1.17%
1 month-3.20%
3 months+7.74%
6 months-11.49%
Current year-21.31%
More quotes
1 week
44.00
Extreme 44
49.46
1 month
34.20
Extreme 34.2
51.15
Current year
34.20
Extreme 34.2
61.12
1 year
23.38
Extreme 23.38
72.30
3 years
23.38
Extreme 23.38
630.00
5 years
23.38
Extreme 23.38
630.00
10 years
9.00
Extreme 9
630.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 Nov. 19
Director of Finance/CFO 39 21-11-30
Chief Operating Officer 56 23-02-28
Members of the board TitleAgeSince
Chairman 79 22-04-25
Director/Board Member 62 22-12-31
Director/Board Member 68 19-12-17
More insiders
Date Price Change Volume
24-05-31 44.82 -2.01% 192,587
24-05-30 45.74 +2.97% 87,348
24-05-29 44.42 -2.46% 140,472
24-05-28 45.54 -0.91% 167,825
24-05-27 45.96 +3.75% 483,910

Delayed Quote Nasdaq Stockholm, May 31, 2024 at 11:29 am EDT

More quotes
BICO Group AB, previously Cellink AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The Company develops and markets technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. The Company’s operations divided in two segments: The Industrial Solutions segment that offers products within precision dispensing and biosensor technology for industrial customers, which make a high-capacity contribution to customers production; and The Laboratory Solutions segment that offers 3Dprinters, single- cell and liquid- dispensing instruments as well as services and consumables related to these products.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
44.82 SEK
Average target price
132.5 SEK
Spread / Average Target
+195.63%
Consensus

Annual profits - Rate of surprise